Drug cocktail aims to stop liver cancer recurrence after surgery
NCT ID NCT07018947
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study tests whether combining two drugs, atezolizumab and bevacizumab, given before and after surgery can help prevent liver cancer from coming back. It enrolls adults with a type of liver cancer that can be surgically removed but has a high risk of recurrence. Participants receive the drugs for a limited time before and after surgery, and researchers track how long they remain cancer-free.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Atezolizumab and Bevacizumab
- What this could lead to
- If successful, this approach could lower the chance of liver cancer returning after surgery, offering a new treatment path for high-risk patients.
- What could go wrong
- This is a Phase 2 trial with a small number of participants, so results may not apply broadly. The drugs can cause serious side effects like bleeding or immune reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital General Universitario Gregorio Marañón
RECRUITINGMadrid, Madrid, 28007, Spain
Contact
Contact
-
Hospital Universitari Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08916, Spain
Contact
Contact
-
Hospital Universitari Josep Trueta
RECRUITINGGirona, Girona, 17007, Spain
Contact
Contact
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, Barcelona, Spain
Contact
Contact
-
Hospital Universitari de Bellvitge
RECRUITINGBarcelona, Barcelona, 08907, Spain
Contact
Contact
-
Hospital Universitario Fundación Jiménez Díaz
RECRUITINGMadrid, Madrid, 28040, Spain
Contact
Contact
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
Contact
Contact
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, Madrid, 28034, Spain
Contact
Contact
-
Hospital Universitario Reina Sofía
RECRUITINGCórdoba, Cordoba, 14004, Spain
Contact
Contact
-
Hospital Universitario Virgen de la Victoria
RECRUITINGPuerto de la Torre, Málaga, 29010, Spain
Contact
Contact
-
Hospital Universitario de Cruces
RECRUITINGBarakaldo, Vizcaya, 48903, Spain
Contact
Contact
-
Hospital Universitario y Politécnico La Fe
RECRUITINGValencia, Valencia, 46026, Spain
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Triple immunotherapy cocktail aims to boost surgery success in liver cancer
- New blood test aims to catch liver cancer recurrence early
- New drug combo shows promise in shrinking liver tumors before surgery
- New drug combo aims to shrink liver tumors before surgery
- New combo therapy aims to boost liver cancer surgery success
- Liver cancer patients get Pre-Surgery combo: radiation plus immunotherapy shows promise